NEW ORLEANS, Dec. 15, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 5, 2018 to file lead plaintiff applications in a securities class action lawsuit against OSI Systems Inc. (Nasdaq:OSIS), if they purchased the Company’s securities between August 16, 2013 and December 6, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Get Help
OSI Systems investors should visit us at https://www.claimsfiler.com/cases/view-osi-systems-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
OSI Systems and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On December 6, 2017, Muddy Waters Research reported several allegations of corrupt business practices by the Company. Specifically, that an Albania concession was acquired through bribery or other improper measures; an unannounced transfer of 49% of its project company, S2 Albania SHPK, to an Albanian holding company for consideration of less than $5.00; and, based on information from former employees, other unlawful acts including improper sales, bribery and fraud.
On this news, the price of OSI Systems’ shares plummeted $24.55 per share, or 29.2%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users 



